5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE
CAS 5034-77-5
Concern score
Not assessed — no hazard data yet.
5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE in plain language
Also known as Imidazole mustard · Bic · 5-(3,3-BIS(2-CHLOROETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE · T69179
We don't have a plain-language description for 5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE yet.
- We haven't assessed a concern score for this ingredient yet.
What we know about this ingredient
EPA DSSTox provides the canonical identifier, structure, and synonym profile for this chemical.
Regulation
No restrictions found. 5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE appears in these published regulatory listings.
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Evidence & sources
No graded research studies for 5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Where this comes from
Reference links (1)
Allergen profile
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
- MustardContains · Oral (ingested)
Source: chemindex_name_match
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
Found in these products
Their ingredient lists include 5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE; each product's own rating depends on its whole formula, so it is shown on the product page, not here.
